Phase II Study to Investigate the Efficacy of Panitumumab in Platinum-resistant Advanced Head and Neck Squamous Cance
Latest Information Update: 29 Oct 2021
At a glance
- Drugs Panitumumab (Primary)
- Indications Head and neck cancer; Squamous cell cancer
- Focus Biomarker; Therapeutic Use
Most Recent Events
- 09 Jan 2016 New trial record